Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you are taking testosterone replacement therapy and considering Mounjaro for weight management, the most important thing to know upfront is this: there is currently no direct clinical trial evidence showing that tirzepatide interacts adversely with TRT, but both treatments affect hormone physiology in overlapping ways, and your prescriber needs to know about every medicine you take. Mounjaro is a prescription-only medicine licensed for weight management in adults with a BMI of 30 or above, or 27 or above with a weight-related condition. Starting it alongside TRT requires a full clinical review, not a quick tick-box.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is: not directly, in the pharmacological sense. Tirzepatide (the active ingredient in Mounjaro) works on GIP and GLP-1 receptors involved in appetite regulation and glucose control. Testosterone, whether injected, applied as a gel, or delivered via patch, enters the bloodstream through a completely different route. Because Mounjaro's well-documented effect on gastric emptying applies to things passing through the gut, it does not slow the absorption of injectable testosterone (such as Sustanon or Nebido) or topical preparations at all.
Where the two therapies genuinely do intersect is in their downstream effects on body composition. Mounjaro produces substantial fat loss in many people; the SURMOUNT-1 trial, published in the New England Journal of Medicine, recorded average weight reductions of around 20% over 72 weeks at the highest dose. Fat tissue is itself a site of oestrogen production and testosterone conversion, so losing a significant amount of it changes the hormonal environment. Men who have been stable on a TRT dose for years may find that their clinical picture shifts as their body composition changes, not because the medicines clash, but because the biology moves beneath both of them. Your TRT prescriber should be aware that you are starting tirzepatide, and the dose of testosterone you need may warrant re-evaluation once meaningful weight loss has occurred.
This is also the reason some men notice changes in libido, energy or mood during the weight-loss phase of treatment that can be tricky to attribute cleanly. It is worth keeping both prescribers in the loop rather than adjusting anything unilaterally. Mounjaro and erectile dysfunction covers some of the overlapping questions men raise about sexual health on treatment.
Yes, low testosterone is associated with reduced lean muscle mass, increased visceral fat, and lower energy levels, all of which make sustained weight loss more difficult. TRT can help correct this, and many men find that being on an optimised testosterone level makes diet and exercise changes more effective. Mounjaro addresses weight through a different lever: reducing appetite and slowing caloric intake rather than directly altering hormone levels. Used alongside an appropriately managed TRT regimen, the two can work in the same direction, supporting body composition improvement from different angles.
What tirzepatide does not do is compensate for undiagnosed or undertreated hypogonadism. If fatigue, poor muscle recovery, mood changes or unexplained weight gain are primarily driven by low testosterone, treating the testosterone deficiency is the clinical priority. Mounjaro is licensed for weight management alongside a reduced-calorie diet and increased physical activity, it is part of a broader plan, not a replacement for addressing the underlying hormonal picture. The Mounjaro treatment overview explains the licensed indication in more detail.
Men on TRT who are also carrying significant excess weight may meet the eligibility criteria for tirzepatide. A BMI of 30 or above, or 27 or above with a condition such as type 2 diabetes, hypertension or dyslipidaemia, generally brings someone into scope. The prescriber assesses the full picture (current medications, comorbidities, and clinical history) before any treatment is approved.
A few are worth knowing about. Haematocrit (the proportion of red blood cells in the blood) is already a standard monitoring point for men on TRT, since testosterone can raise it; men losing a substantial amount of weight may see shifts in blood volume and concentration that merit an updated check. This is not a reason to avoid the combination, but a reason to stay current with the bloods your TRT prescriber has already arranged.
Mounjaro carries a Black Triangle (▼) designation with the MHRA, meaning it is subject to additional monitoring as a relatively new medicine. You can read the NHS patient information for tirzepatide for a plain-English overview of what to watch for. Common side effects are predominantly gastrointestinal (nausea, diarrhoea, constipation, reflux) most noticeable at the start of treatment or after a dose step up, and they tend to settle as the body adjusts. These are not unique to men on TRT, but if persistent vomiting is affecting your ability to eat adequately, that can affect muscle mass and should be flagged quickly.
Men taking oral medicines alongside either treatment should raise that with their prescriber. For tirzepatide specifically, the NHS England guidance on weight-management injections notes that the oral contraceptive pill's absorption may be affected, and the same reasoning applies in principle to any time-critical oral medicine. If you take an oral testosterone preparation rather than an injection or gel (which is less common in the UK) this is a specific question worth raising. Some men also ask whether Mounjaro affects their ears or hearing as they lose weight, and our page on Mounjaro and clogged ears addresses what is known about that. Tirzepatide's broader interaction with hormone-related treatments is covered in our pages on tirzepatide and TRT and Mounjaro and HRT.
Every order through a regulated service starts with a clinical consultation. At nume, a GPhC-registered Independent Prescriber reads your medical history (including your current medications) before any approval decision is made. A prescriber, not software, makes that call. You will be asked about TRT: what you are taking, how it is administered, and who manages it. Disclosing this is in your interest; it is how the prescriber determines whether Mounjaro is appropriate and flags anything your TRT clinician should know.
If approved, your Mounjaro KwikPen arrives the next working day via DPD, in plain unbranded packaging, with a tracking notification to your phone. The pen contains four weekly doses, pre-filled and ready to use following the instructions in the leaflet. The pharmacy you use should be verifiable on the GPhC register at pharmacyregulation.org. Fake pens are a real risk when medicines are sold online without a prescription, the MHRA has warned publicly about counterfeit weight-loss injections and made large seizures of them across the UK. Price questions about private treatment are covered honestly on the Mounjaro price context page. If you have other questions about how our service works, our about page sets it out plainly. Speak to our prescribers through a free consultation if you want an assessment that takes your TRT into account from the start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.